Clinical Trial Update: Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain [Phase 3]

View source ↗

Summary

An update on a Phase 3 trial evaluating the effectiveness and safety of ziconotide for chronic severe pain; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Prialt (ziconotide)

Snippet

Sponsor: Elan Pharmaceuticals | Conditions: Pain | Phase 3 | Status: COMPLETED